TITLE

Dosimetric comparison of volumetric modulated Arc therapy, step-and-shoot, and sliding window IMRT for prostate cancer

AUTHOR(S)
Schnell, Erich; Herman, Tania De La Fuente; Young, Julie; Hildebrand, Kim; Algan, Ozer; Syzek, Elizabeth; Herman, Terence; Ahmad, Salahuddin
PUB. DATE
October 2012
SOURCE
AIP Conference Proceedings;Oct2012, Vol. 1494 Issue 1, p23
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This study aims to evaluate treatment plans generated by Step-and-Shoot (SS), Sliding Window (SW) and Volumetric Modulated Arc Therapy (VMAT) in order to assess the differences in dose volume histograms of planning target volume (PTV) and organs at risk (OAR), conformity indices, radiobiological evaluations, and plan quality for prostate cancer cases. Six prostate cancer patients treated in our center were selected for this retrospective study. Treatment plans were generated with Eclipse version 8.9 using 10 MV photon beams. For VMAT, Varian Rapid Arc with 1 or 2 arcs, and for SS and SW IMRT, 7-9 fields were used. Each plan had three PTVs with prescription doses of 81, 59.4, and 45 Gy to prostate, to prostate and lymph nodes, and to pelvis, respectively. Doses to PTV and OAR and the conformal indices (COIN) were compared among three techniques. The equivalent uniform dose (EUD), tumor control probability (TCP) and normal tissue complication probability (NTCP) were calculated and compared. The mean doses to the PTV prostate on average were 83 Gy and the percent differences of mean dose among all techniques were below 0.28. For bladder and rectum, the percent differences of mean dose among all techniques were below 2.2. The COIN did not favour any particular delivery method over the other. The TCP was higher with SS and SW for four patients and higher with VMAT for two patients. The NTCP for the rectum was the lowest with VMAT in five out of the six patients. The results show similar target coverage in general.
ACCESSION #
82713024

 

Related Articles

  • Early clinical experience of radiotherapy of prostate cancer with volumetric modulated arc therapy. Pesce, Gianfranco A.; Clivio, Alessandro; Cozzi, Luca; Nicolini, Giorgia; Richetti, Antonella; Salati, Emanuela; Valli, Mariacarla; Vanetti, Eugenio; Fogliata, Antonella // Radiation Oncology;2010, Vol. 5, p54 

    Background: To report about initial clinical experience in radiation treatment of carcinoma of prostate with volumetric modulated arcs with the RapidArc (RA) technology. Methods: Forty-five patients with a median age of 72 ± 3, affected by prostate carcinoma (T1c: 22 patients, T2a-b: 17...

  • Shorter Radiation Course May Improve PCa Control. SCHIESZER, JOHN // Renal & Urology News;Jan2010, Vol. 9 Issue 1, p15 

    The article focuses on the findings of a study related to the use of hypofractionated stereotactic body radiotherapy in the treatment of high-risk prostate cancer. The study revealed that hypofractionated radiation treatment can improve outcomes in the prostate cancer patients. Researcher,...

  • Dosimetric impact of Acuros XB dose calculation algorithm in prostate cancer treatment using RapidArc. Rana, Suresh; Rogers, Kevin; Lee, Terry; Reed, Daniel; Biggs, Christopher // Journal of Cancer Research & Therapeutics;Jul-Sep2013, Vol. 9 Issue 3, p430 

    Purpose: The purpose of this study is to assess the dosimetric impact of Acuros XB dose calculation algorithm (AXB), in comparisons with Anisotropic Analytical Algorithm (AAA) calculations in prostate cancer treatment using RapidArc. Materials and Methods: A computed tomography (CT) dataset of...

  • Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry. McDonald, Andrew M.; Bishop, Justin M.; Jacob, Rojymon; Dobelbower, Michael C.; Kim, Robert Y.; Yang, Eddy S.; Smith, Heather; Xingen Wu; Fiveash, John B. // Prostate Cancer (20903111);2012, p1 

    Purpose. To evaluate toxicity associated with the addition of elective nodal irradiation (ENI) to a hypofractionated regimen for the treatment of prostate cancer. Methods and Materials. Fifty-seven patients received pelvic image-guided IMRT to 50.4Gy in 28 fractions with a hypofractionated...

  • Use of a correlation analysis model in the optimization of intensity-modulated radiotherapy of prostate cancer. XIADONG LI; QINGHUA DENG; SHENGLIN MA; KE ZHANG; ZHIBING WU; JIANJUN LAI; RONGJUN TANG; YAO REN; JIAHAO WANG; LIXIA XU // Experimental & Therapeutic Medicine;Dec2015, Vol. 10 Issue 6, p2187 

    The aim of the present study was to develop a statistical model-based method for the optimization of intensity-modulated radiotherapy (IMRT). A prostate cancer IMRT plan was redesigned while retaining the same beam orientation and prescribed dose as the regular plan. A series of dosimetric...

  • Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis? Cho, Yeona; Chang, Jee Suk; Rha, Koon Ho; Hong, Sung Joon; Choi, Young Deuk; Ham, Won Sik; Kim, Jun Won; Cho, Jaeho // PLoS ONE;1/25/2016, Vol. 11 Issue 1, p1 

    Purpose/Objectives: Treatment of the primary tumor reportedly improves survival in several types of metastatic cancer. We herein evaluated the efficacy and toxicity of radiotherapy for the primary tumor in prostate cancer with metastasis. Materials/Methods: The study cohort included 140 men...

  • 1st RapidArc treatment performed in Spain.  // Medical Device Daily;6/3/2010, Vol. 14 Issue 106, p8 

    The article reports on the first treatment using RapidArc radiotherapy from Varian Medical Systems conducted by clinicians at Institut Catala d'Oncologia on a 73-year-old prostate cancer patient from Barcelona, Spain.

  • Can we decrease the acute proctitis in prostate cancer patients using hyaluronic acid during radiation therapy: a prospective historically controlled clinical study. Cartei, G. // European Review for Medical & Pharmacological Sciences;May2013, Vol. 17 Issue 9, p1279 

    A letter to the editor is presented in response to the article "Safety and Efficacy of Radiotherapy Treatment in Elderly Patients With Localized Prostate Cancer: A Retrospective Analysis" by F. Fiorica et al.

  • The best method for dose escalation: Prostate brachytherapy. Morton, Gerard // Canadian Urological Association Journal;Jun2012, Vol. 6 Issue 3, p196 

    The author discusses the role of radiation therapy dose in the treatment of prostate cancer. He informs that external beam radiotherapy dose increases the biochemical control rate to about 10 percent in five years and also mentions that brachytherapy is a safe method of dose escalation. He...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics